In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry

25B-NBF, 2-(4-bromo-2,5-dimethoxyphenyl)-<i>N</i>-(2-fluorobenzyl)ethanamine, is a new psychoactive substance classified as a phenethylamine. It is a potent agonist of the 5-hydroxytryptamine receptor, but little is known about its metabolism and elimination properties since it was disco...

Full description

Bibliographic Details
Main Authors: Ju-Hyun Kim, Sunjoo Kim, Jaesin Lee, Sangwhan In, Yong-Yeon Cho, Han Chang Kang, Joo Young Lee, Hye Suk Lee
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/4/818
_version_ 1811309990900662272
author Ju-Hyun Kim
Sunjoo Kim
Jaesin Lee
Sangwhan In
Yong-Yeon Cho
Han Chang Kang
Joo Young Lee
Hye Suk Lee
author_facet Ju-Hyun Kim
Sunjoo Kim
Jaesin Lee
Sangwhan In
Yong-Yeon Cho
Han Chang Kang
Joo Young Lee
Hye Suk Lee
author_sort Ju-Hyun Kim
collection DOAJ
description 25B-NBF, 2-(4-bromo-2,5-dimethoxyphenyl)-<i>N</i>-(2-fluorobenzyl)ethanamine, is a new psychoactive substance classified as a phenethylamine. It is a potent agonist of the 5-hydroxytryptamine receptor, but little is known about its metabolism and elimination properties since it was discovered. To aid 25B-NBF abuse screening, the metabolic characteristics of 25B-NBF were investigated in human hepatocytes and human cDNA-expressed cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes using liquid chromatography&#8315;high resolution mass spectrometry. At a hepatic extraction ratio of 0.80, 25B-NBF was extensively metabolized into 33 metabolites via hydroxylation, <i>O</i>-demethylation, bis-<i>O</i>-demethylation, <i>N</i>-debenzylation, glucuronidation, sulfation, and acetylation after incubation with pooled human hepatocytes. The metabolism of 25B-NBF was catalyzed by CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2J2, CYP3A4, and UGT2B7 enzymes. Based on these results, it is necessary to develop a bioanalytical method for the determination of not only 25B-NBF but also its metabolites in biological samples for the screening of 25B-NBF abuse.
first_indexed 2024-04-13T09:51:53Z
format Article
id doaj.art-5dbc3b48b9b4422986e9ba1194bc6a68
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-13T09:51:53Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-5dbc3b48b9b4422986e9ba1194bc6a682022-12-22T02:51:34ZengMDPI AGMolecules1420-30492019-02-0124481810.3390/molecules24040818molecules24040818In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass SpectrometryJu-Hyun Kim0Sunjoo Kim1Jaesin Lee2Sangwhan In3Yong-Yeon Cho4Han Chang Kang5Joo Young Lee6Hye Suk Lee7BK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, KoreaBK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, KoreaNational Forensic Service, Wonju 24460, KoreaNational Forensic Service, Wonju 24460, KoreaBK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, KoreaBK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, KoreaBK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, KoreaBK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Korea25B-NBF, 2-(4-bromo-2,5-dimethoxyphenyl)-<i>N</i>-(2-fluorobenzyl)ethanamine, is a new psychoactive substance classified as a phenethylamine. It is a potent agonist of the 5-hydroxytryptamine receptor, but little is known about its metabolism and elimination properties since it was discovered. To aid 25B-NBF abuse screening, the metabolic characteristics of 25B-NBF were investigated in human hepatocytes and human cDNA-expressed cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes using liquid chromatography&#8315;high resolution mass spectrometry. At a hepatic extraction ratio of 0.80, 25B-NBF was extensively metabolized into 33 metabolites via hydroxylation, <i>O</i>-demethylation, bis-<i>O</i>-demethylation, <i>N</i>-debenzylation, glucuronidation, sulfation, and acetylation after incubation with pooled human hepatocytes. The metabolism of 25B-NBF was catalyzed by CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2J2, CYP3A4, and UGT2B7 enzymes. Based on these results, it is necessary to develop a bioanalytical method for the determination of not only 25B-NBF but also its metabolites in biological samples for the screening of 25B-NBF abuse.https://www.mdpi.com/1420-3049/24/4/81825B-NBF metabolismliquid chromatography-high resolution mass spectrometryhuman hepatocyteCYPUGT
spellingShingle Ju-Hyun Kim
Sunjoo Kim
Jaesin Lee
Sangwhan In
Yong-Yeon Cho
Han Chang Kang
Joo Young Lee
Hye Suk Lee
In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
Molecules
25B-NBF metabolism
liquid chromatography-high resolution mass spectrometry
human hepatocyte
CYP
UGT
title In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
title_full In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
title_fullStr In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
title_full_unstemmed In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
title_short In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-<i>N</i>-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry
title_sort in vitro metabolism of 25b nbf 2 4 bromo 2 5 dimethoxyphenyl i n i 2 fluorobenzyl ethanamine in human hepatocytes using liquid chromatography mass spectrometry
topic 25B-NBF metabolism
liquid chromatography-high resolution mass spectrometry
human hepatocyte
CYP
UGT
url https://www.mdpi.com/1420-3049/24/4/818
work_keys_str_mv AT juhyunkim invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT sunjookim invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT jaesinlee invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT sangwhanin invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT yongyeoncho invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT hanchangkang invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT jooyounglee invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry
AT hyesuklee invitrometabolismof25bnbf24bromo25dimethoxyphenylini2fluorobenzylethanamineinhumanhepatocytesusingliquidchromatographymassspectrometry